Antimicrobial peptides in human synovial membrane as (low-grade) periprosthetic joint infection biomarkers

Ingo J Banke1, Niko Stade2, Peter M Prodinger2

  • 1Clinic of Orthopedics and Sports Orthopedics, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Strasse 22, 81675, Munich, Germany. ingo.banke@mri.tum.de.

Abstract

Insights

Antimicrobial peptides (AMPs), specifically human cathelicidin LL-37 and beta-defensin-3 (HBD-3), show high accuracy for diagnosing periprosthetic joint infection (PJI). These AMPs in synovial membranes and cells offer a promising tool for histological PJI diagnosis.

Area of Science:

  • Orthopedics and Infectious Disease Research
  • Biomarker Discovery for Infection Diagnosis
  • Immunology of Prosthetic Joint Infections

Background:

  • Accurate diagnosis of periprosthetic joint infection (PJI) is critical for successful joint replacement surgery.
  • Current diagnostic methods lack sufficient accuracy for chronic, low-grade PJI.
  • Antimicrobial peptides (AMPs) are key components of the innate immune response to infection.

Purpose of the Study:

  • To evaluate human cathelicidin LL-37 and beta-defensin-3 (HBD-3) as biomarkers in synovial membranes and synoviocytes for PJI diagnosis.
  • To assess the diagnostic accuracy of these AMPs in histological samples.
  • To improve the histological diagnosis of PJI and enhance patient outcomes.

Main Methods:

  • Prospective single-center study including patients undergoing primary arthroplasty, aseptic loosening revision, and septic arthroplasty.
  • Immunohistochemical analysis of LL-37, HBD-3, and HBD-2 in synovial membranes and isolated synoviocytes.
  • Semiquantitative scoring (TS and IRS) and receiver operating characteristic (ROC) curve analysis for diagnostic accuracy.

Main Results:

  • LL-37 and HBD-3 were significantly elevated (up to 20x) in PJI synovial membranes compared to controls.
  • Both LL-37 and HBD-3 demonstrated excellent diagnostic accuracy (AUC=1.0) in ROC analysis.
  • Isolated synoviocytes also showed increased LL-37/HBD-3 levels in PJI, with HBD-2 showing negligible levels and lower diagnostic accuracy.

Conclusions:

  • AMPs, particularly LL-37 and HBD-3, are highly promising and specific biomarkers for the histological diagnosis of PJI.
  • The findings support the use of AMPs in synovial membranes and cells to improve PJI diagnosis.
  • This research contributes to better diagnostic strategies for septic joint replacement outcomes.